IRTCiRhythm Technologies, Inc.

IRTC Stock Price, Valuation & Chart | iRhythm Technologies, Inc.

Compare

$104.99-2.21 (-2.06%)

At close · 07 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices

Overview Financials Dividends Ratios

IRTC Historical price chart

IRTC Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization3.45B

PE Ratio-244.1

EPS-0.43

Trading Volume449.79K

Today's High/Low108.01/104.7

Dividend Yield0.00

52 Week High/Low212.0/100.85

Shares Outstanding32.86M

IRTC Financial Statement

IRTC Analyst ratings

IRTC Analysis & performance metrics

IRTC Company profile

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United…

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients…

IRTC Management team

Name

Position

Daniel G. WilsonCFO

Chief Financial Officer, Principal Financial Officer, EVice President of Corporate Development & Investor Relations

Minang P. Turakhia M.D., M.S.

Chief Medical & Scientific Officer and Executive Vice President of Product Innovation

Mervin Smith

Executive Vice President of Business Operations

Marc Rosenbaum

Senior Vice President of Finance & Chief Accounting Officer

Patrick Michael Murphy J.D.

Chief Business & Legal Officer

Sumi Shrishrimal

Executive Vice President & Chief Risk Officer

Chad M. Patterson

Chief Commercial Officer

Quentin S. BlackfordCEO

President, Chief Executive Officer & Director

Name

Position

Daniel G. WilsonCFO

Chief Financial Officer, Principal Financial Officer, EVice President of Corporate Development & Investor Relations

Minang P. Turakhia M.D., M.S.

Chief Medical & Scientific Officer and Executive Vice President of Product Innovation

Mervin Smith

Executive Vice President of Business Operations

Marc Rosenbaum

Senior Vice President of Finance & Chief Accounting Officer

Patrick Michael Murphy J.D.

Chief Business & Legal Officer

Sumi Shrishrimal

Executive Vice President & Chief Risk Officer

Chad M. Patterson

Chief Commercial Officer

Quentin S. BlackfordCEO

President, Chief Executive Officer & Director

Management Team

Daniel G. WilsonCFO

Chief Financial Officer, Principal Financial Officer, EVice President of Corporate Development & Investor Relations

Minang P. Turakhia M.D., M.S.

Chief Medical & Scientific Officer and Executive Vice President of Product Innovation

Mervin Smith

Executive Vice President of Business Operations

Marc Rosenbaum

Senior Vice President of Finance & Chief Accounting Officer

Patrick Michael Murphy J.D.

Chief Business & Legal Officer

Sumi Shrishrimal

Executive Vice President & Chief Risk Officer

Chad M. Patterson

Chief Commercial Officer

Quentin S. BlackfordCEO

President, Chief Executive Officer & Director

Management

Daniel G. WilsonCFO

Chief Financial Officer, Principal Financial Officer, EVice President of Corporate Development & Investor Relations

Minang P. Turakhia M.D., M.S.

Chief Medical & Scientific Officer and Executive Vice President of Product Innovation

Mervin Smith

Executive Vice President of Business Operations

Marc Rosenbaum

Senior Vice President of Finance & Chief Accounting Officer

Patrick Michael Murphy J.D.

Chief Business & Legal Officer

Sumi Shrishrimal

Executive Vice President & Chief Risk Officer

Chad M. Patterson

Chief Commercial Officer

Quentin S. BlackfordCEO

President, Chief Executive Officer & Director

Total 8 executives

IRTC Frequently asked questions

What is iRhythm Technologies, Inc. (IRTC) Stock Price?

Current stock price of iRhythm Technologies, Inc. (IRTC) stock is $104.99. The stock price is -2.06% lower in the session. The intraday range can be seen from this page. Volume of iRhythm Technologies, Inc. (IRTC) stock is 449.79K.

Last updated at 07 Oct 2026, 08:00 pm.

Why is the iRhythm Technologies, Inc. (IRTC) stock price going up or down today?

The stock price of iRhythm Technologies, Inc. (IRTC) can change with earnings, company news, and overall market sentiment. iRhythm Technologies, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the iRhythm Technologies, Inc. stock expensive at its current price?

Whether iRhythm Technologies, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IRTC on this page is -244.16. EPS on this page is -0.43. Compare those figures with peers and growth expectations before deciding if the current iRhythm Technologies, Inc. price is justified.

How has the stock price of iRhythm Technologies, Inc. (IRTC) performed historically?

Historical performance for iRhythm Technologies, Inc. (IRTC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IRTC reacted to past earnings and market events.

Should I buy iRhythm Technologies, Inc. (IRTC) stock, at this price?

Buying iRhythm Technologies, Inc. (IRTC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.